Celgene (CELG) PT Raised to $135 at Leerink Partners Following 4Q
Tweet Send to a Friend
Leerink Partners raised its price target on Celgene (NASDAQ: CELG) to $135.00 (from $129.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
